Get the Stockscreener App
17.91
1.76%
0.31
After Hours:
18.20
0.29
+1.62%
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Latest News
Centessa Pharmaceuticals' chief business officer sells $176,601 in shares - Investing.com India
Centessa Pharmaceuticals CEO Saha Saurabh sells $5,450 in shares - Investing.com
Centessa Pharmaceuticals CEO Saurabh sells shares worth $1.02 million By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals CEO Saurabh sells shares worth $1.02 million - Investing.com
Deutsche Bank initates Fidelity National Financial Inc (FNF) stock to a Hold - Knox Daily
Centessa Pharmaceuticals CEO sells shares worth $585,418 - Investing.com India
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update - GlobeNewswire Inc.
Endava PLC Sponsored ADR (DAVA) Beats Q1 Earnings Estimates - Yahoo Finance
Centessa Pharmaceuticals' chief business officer sells shares for $180,628 - Investing.com
Centessa Pharmaceuticals plcADR (CNTA) Price Target Increased by 14.58% to 11.22 - MSN
Centessa Pharmaceuticals CEO sells shares worth $863,727 - Investing.com
Are Finance Stocks Lagging Balfour Beatty PLC Sponsored ADR (BLFBY) This Year? - Yahoo Finance
Centessa Pharmaceuticals plc ADR (CNTA) expanding its growth trajectory ahead - SETE News
GSK Plc ADR [GSK] Insider Activity: An Update for Investors - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Analysts review Bilibili Inc ADR’s rating - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) shows promising results - US Post News
Ratios Uncovered: Breaking Down Centessa Pharmaceuticals plc ADR (CNTA)’s Trailing Twelve Months Metrics - The Dwinnex
Centessa Pharmaceuticals executive sells over $260k in company stock - Investing.com India
Centessa Pharmaceuticals executive sells over $260k in company stock By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals plc ADR [CNTA] Shares Rise 2.15 % on Thursday - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) is looking forward to a strong quarter - SETE News
Centessa's ORX142 shows promise for treating daytime sleepiness - Investing.com India
Monitoring Accenture plc (ACN) after recent insider movements - Knox Daily
ALLE stock rated an Underweight by Barclays - Knox Daily
Understanding the Risks of Investing in BranchOut Food Inc (BOF) - Knox Daily
EON Resources Inc. [EONR] Investment Guide: What You Need to Know - Knox Daily
Analysts review Reneo Pharmaceuticals Inc’s rating - Knox Daily
Analyzing Pineapple Energy Inc (PEGY) After Recent Trading Activity - Knox Daily
Investing in nVent Electric plc (NVT): What You Must Know - Knox Daily
Peraso Inc’s latest rating changes from various analysts - Knox Daily
Fiserv, Inc. [FI] Insider Bisignano Frank sells 145,000 Shares – Latest Insider Activity - Knox Daily
The Attractiveness of Investing In GE Aerospace (GE) is Growing - Knox Daily
President and CEO, MADER MARK PATRICK sold 20,000 shares of Smartsheet Inc [SMAR] - Knox Daily
Henry Schein Inc. [HSIC] Insider McGlynn Lorelei sells 21,035 Shares – McGlynn Lorelei Activity - Knox Daily
A Guide To The Risks Of Investing In Autodesk Inc. (ADSK) - Knox Daily
Is it a good time to sell Xcel Energy, Inc. [XEL] shares after an insider sold 2,041 shares? - Knox Daily
Chief Executive Officer, Scots-Knight Denise sold 60,046 shares of Mereo Biopharma Group Plc ADR [MREO] - Knox Daily
Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily
Recent Insider Activity Could Benefit Tractor Supply Co. (TSCO) - Knox Daily
Examining the Potential Price Growth of Biomarin Pharmaceutical Inc. (BMRN) - Knox Daily
The Potential Rise in the Price of Ventas Inc (VTR) following insiders activity - Knox Daily
Monitoring Ultragenyx Pharmaceutical Inc. (RARE) after recent insider movements - Knox Daily
Investing in Cannae Holdings Inc (CNNE): What You Must Know - Knox Daily
Analysts review Dyne Therapeutics Inc’s rating - Knox Daily
Citigroup analysts initates a Buy rating for Crinetics Pharmaceuticals Inc (CRNX) - Knox Daily
Texas Roadhouse Inc [TXRH] Insider Jones Wayne L. sells 700 Shares – Insider Selling Alert - Knox Daily
The Potential Rise in the Price of TransUnion (TRU) following insiders activity - Knox Daily
An Analysis of Trane Technologies plc (TT)’s Potential Price Growth - Knox Daily
OneMain Holdings Inc (OMF) gets rating Initiated from BTIG Research - Knox Daily
Chipotle Mexican Grill [CMG] Investment Appeal on the Rise - Knox Daily
Macrogenics Inc (MGNX) may enjoy gains as insiders got busy in the recent days - Knox Daily
Investing in CareTrust REIT Inc (CTRE) Is Getting More Attractive - Knox Daily
TD Cowen’s latest rating for KBR stock - Knox Daily
Upwork Inc (UPWK) Becoming More Attractive for Investors - Knox Daily
Investing in Trio Petroleum Corp. (TPET) Is Getting More Attractive - Knox Daily
Everi Holdings Inc (EVRI) gets rating Resumed from B. Riley Securities - Knox Daily
Recent Insider Activity Could Benefit Janus Henderson Group plc (JHG) - Knox Daily
JCI (Johnson Controls International plc) may reap gains as insiders became active recently - Knox Daily
Investing in Coursera Inc (COUR) Is Getting More Attractive - Knox Daily
MULN’s latest rating updates from top analysts. - Knox Daily
Recent Insider Activity Suggests Potential Gains for 3M Co. (MMM) - Knox Daily
ARS Pharmaceuticals Inc [SPRY] Investment Appeal on the Rise - Knox Daily
Monitoring Perrigo Company plc (PRGO) after recent insider movements - Knox Daily
AEO stock rated a Market perform by Telsey Advisory Group - Knox Daily
Evercore ISI upgrades Darden Restaurants, Inc. (DRI) rating to an Outperform - Knox Daily
Is Centessa Pharmaceuticals plc ADR (CNTA) worth investing in despite its undervalued state? - US Post News
Market Insight: Centessa Pharmaceuticals plc ADR (CNTA)’s Notable Gain, Closing at 16.58 - The Dwinnex
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):